The U.S. Food and Drug Administration announced the availability of a draft guidance aimed at increasing the amount of safety information the agency has about the dietary supplement marketplace by providing the industry an opportunity to submit late new dietary ingredient (NDI) notifications.

GlaxoSmithKline said on April 6 the company’s consumer arm stopped shipments of supplements and vitamins to Russia as a result of Moscow’s invasion of Ukraine and would prioritize the supply of over-the-counter medicines for basic needs.

In this webinar, you will hear from the Kline Group about a trend moving into dietary supplements, and from Catalent about how supplement brands are accelerating toward a more natural, plant–based portfolio, including in the ever–important heart health market.

Shares of Amarin Corporation were down more than 70 percent in trading after a judge ruled that generic companies can go ahead and seek approval of generic versions of the drug manufacturer’s heart disease drug Vascepa.

Today, the U.S. Food and Drug Administration took an important step to better protect consumers from the dangers of highly concentrated and pure caffeine products. These products present a significant public health threat because of the high risk that they will be erroneously used at excessive, potentially dangerous doses. Highly concentrated and pure caffeine, often sold in bulk packages, have been linked to at least two deaths in otherwise healthy individuals.

PHOENIX–(BUSINESS WIRE)–EXOS, the leader in proactive health and performance solutions, today announced a partnership with Odell Beckham Jr. — the NFL’s 2014 Rookie of the Year — as a brand […]

DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/5ht5nd/global_fish_oil) has announced the addition of the “Global Fish Oil Market (Application, Species and Geography) – Country Analysis, Size, Share, Trends, Company Profiles, Demand, Growth, Opportunities […]